AEterna Zentaris Skin Disease Drug Wins Approval in Colombia

Drugmaker AEterna Zentaris Inc. said its Impavido treatment for the skin-affecting form of the disease leishmaniasis has been approved by the Colombian Food and Drug Agency. The approval was the first for Impavido as a treatment for the disease on skin, AEterna said.

Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=bc7923e9388a7f21&cat=6dcd932030878143)